Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $19.14 in the prior trading day, Alignment Healthcare Inc (NASDAQ: ALHC) closed at $19.22, up 0.42%. In other words, the price has increased by $0.42 from its previous closing price. On the day, 2.21 million shares were traded. ALHC stock price reached its highest trading level at $19.4 during the session, while it also had its lowest trading level at $19.02.
Ratios:
Our goal is to gain a better understanding of ALHC by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 2.04 whereas as Long-Term Debt/Eq ratio is at 2.04.
On October 14, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $21.
KeyBanc Capital Markets Upgraded its Sector Weight to Overweight on August 25, 2025, while the target price for the stock was maintained at $21.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 25 ’25 when KONOWIECKI JOSEPH S sold 25,000 shares for $19.00 per share. The transaction valued at 475,000 led to the insider holds 1,056,141 shares of the business.
Joseph Konowiecki bought 25,000 shares of ALHC for $475,000 on Nov 25 ’25. On Nov 11 ’25, another insider, KONOWIECKI JOSEPH S, who serves as the Director of the company, sold 4,832 shares for $16.49 each. As a result, the insider received 79,680 and left with 1,081,141 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3845763072 and an Enterprise Value of 3531341312. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.06 while its Price-to-Book (P/B) ratio in mrq is 23.75. Its current Enterprise Value per Revenue stands at 0.971 whereas that against EBITDA is 99.592.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.15, which has changed by 0.5241872 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $10.18. The 50-Day Moving Average of the stock is 12.36%, while the 200-Day Moving Average is calculated to be 21.56%.
Shares Statistics:
The stock has traded on average 3.18M shares per day over the past 3-months and 2636620 shares per day over the last 10 days, according to various share statistics. A total of 199.99M shares are outstanding, with a floating share count of 161.39M. Insiders hold about 19.32% of the company’s shares, while institutions hold 87.20% stake in the company. Shares short for ALHC as of 1763078400 were 13982386 with a Short Ratio of 4.40, compared to 1760486400 on 13661380. Therefore, it implies a Short% of Shares Outstanding of 13982386 and a Short% of Float of 10.71.
Earnings Estimates
The dynamic stock of Alignment Healthcare Inc (ALHC) is currently being evaluated by a team of 4.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.11, with high estimates of $0.11 and low estimates of $0.11.
Analysts are recommending an EPS of between $0.28 and $0.11 for the fiscal current year, implying an average EPS of $0.21. EPS for the following year is $0.38, with 4.0 analysts recommending between $0.46 and $0.26.
Revenue Estimates
11 analysts predict $1B in revenue for. The current quarter. It ranges from a high estimate of $1.01B to a low estimate of $980M. As of. The current estimate, Alignment Healthcare Inc’s year-ago sales were $701.24MFor the next quarter, 11 analysts are estimating revenue of $1.2B. There is a high estimate of $1.23B for the next quarter, whereas the lowest estimate is $1.17B.
A total of 11 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $3.94B, while the lowest revenue estimate was $3.9B, resulting in an average revenue estimate of $3.94B. In the same quarter a year ago, actual revenue was $2.7BBased on 11 analysts’ estimates, the company’s revenue will be $5.05B in the next fiscal year. The high estimate is $5.2B and the low estimate is $4.93B.
